Company / Income Tax per Share
UroGen Pharma Ltd. Income Tax per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.00
FY2025
5-year range
$0.00 / $0.12
FY2021-FY2025
Trend
-98.5%
vs FY2024
Sector context
#100 of 201
Health Care
What the data says
At $0.00, UroGen Pharma Ltd.'s income tax per share ranks #102 of 201 in the Health Care sector. Income Tax per Share has fluctuated over the past 9 years, ranging from $0.00 in FY2019 to $0.16 in FY2020.
Based on SEC 10-K filings.
0.00 in FY2025 with a 5-year CAGR of -59.1%.
Improved from $0.08 to $0.00 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -69.4%
- 5-Year CAGR
- -59.1%
- 10-Year CAGR
- -
Sector benchmark
#102 of 201 in Health CareTop 50% of 201This company $0.00 Sector average $1.35
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, income tax per share decreased 98.5% year-over-year.
- Ranks #100 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2020.
- Lowest income tax per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.09 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -98.5% |
| FY2024 | $0.12 | +59.0% |
| FY2023 | $0.08 | +17.6% |
| FY2022 | $0.06 | -1.3% |
| FY2021 | $0.07 | -59.3% |
| FY2020 | $0.16 | +13594.5% |
| FY2019 | $0.00 | -87.1% |
| FY2018 | $0.01 | +364.9% |
| FY2017 | $0.00 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026